Quest Diagnostics has received US Food and Drug Administration (FDA) emergency use authorization (EUA) for its monkeypox polymerase chain reaction (PCR) test.
The latest move follows a declaration of monkeypox as a public health emergency by the US Department of Health and Human Services.
The Quest Diagnostics Monkeypox Virus Qualitative Real-Time PCR (Quest Monkeypox PCR) is claimed to be the first test to receive EUA due to the monkeypox public health emergency.